These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 27333042)

  • 41. PTH1 receptor is involved in mediating cellular response to long-chain polyunsaturated fatty acids.
    Candelario J; Tavakoli H; Chachisvilis M
    PLoS One; 2012; 7(12):e52583. PubMed ID: 23300710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Normal human osteoclasts formed from peripheral blood monocytes express PTH type 1 receptors and are stimulated by PTH in the absence of osteoblasts.
    Dempster DW; Hughes-Begos CE; Plavetic-Chee K; Brandao-Burch A; Cosman F; Nieves J; Neubort S; Lu SS; Iida-Klein A; Arnett T; Lindsay R
    J Cell Biochem; 2005 May; 95(1):139-48. PubMed ID: 15723294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Deletion of Hdac4 in Mouse Osteoblasts Influences Both Catabolic and Anabolic Effects in Bone.
    Nakatani T; Chen T; Johnson J; Westendorf JJ; Partridge NC
    J Bone Miner Res; 2018 Jul; 33(7):1362-1375. PubMed ID: 29544022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Salt-inducible kinases dictate parathyroid hormone 1 receptor action in bone development and remodeling.
    Nishimori S; O'Meara MJ; Castro CD; Noda H; Cetinbas M; da Silva Martins J; Ayturk U; Brooks DJ; Bruce M; Nagata M; Ono W; Janton CJ; Bouxsein ML; Foretz M; Berdeaux R; Sadreyev RI; Gardella TJ; Jüppner H; Kronenberg HM; Wein MN
    J Clin Invest; 2019 Dec; 129(12):5187-5203. PubMed ID: 31430259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vps35 loss promotes hyperresorptive osteoclastogenesis and osteoporosis via sustained RANKL signaling.
    Xia WF; Tang FL; Xiong L; Xiong S; Jung JU; Lee DH; Li XS; Feng X; Mei L; Xiong WC
    J Cell Biol; 2013 Mar; 200(6):821-37. PubMed ID: 23509071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Loss of Parathyroid Hormone Receptor Signaling in Osteoprogenitors Is Associated With Accumulation of Multiple Hematopoietic Lineages in the Bone Marrow.
    Kimura T; Panaroni C; Rankin EB; Purton LE; Wu JY
    J Bone Miner Res; 2022 Jul; 37(7):1321-1334. PubMed ID: 35490308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Primary cilia and PTH1R interplay in the regulation of osteogenic actions.
    Ardura JA; Martín-Guerrero E; Heredero-Jiménez S; Gortazar AR
    Vitam Horm; 2022; 120():345-370. PubMed ID: 35953116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physiological and Pharmacological Roles of PTH and PTHrP in Bone Using Their Shared Receptor, PTH1R.
    Martin TJ; Sims NA; Seeman E
    Endocr Rev; 2021 Jul; 42(4):383-406. PubMed ID: 33564837
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analysis of parathyroid hormone (PTH)/secretin receptor chimeras differentiates the role of functional domains in the pth/ pth-related peptide (PTHrP) receptor on hormone binding and receptor activation.
    Vilardaga JP; Lin I; Nissenson RA
    Mol Endocrinol; 2001 Jul; 15(7):1186-99. PubMed ID: 11435617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Osteoblastic expansion induced by parathyroid hormone receptor signaling in murine osteocytes is not sufficient to increase hematopoietic stem cells.
    Calvi LM; Bromberg O; Rhee Y; Weber JM; Smith JN; Basil MJ; Frisch BJ; Bellido T
    Blood; 2012 Mar; 119(11):2489-99. PubMed ID: 22262765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RANKL/OPG system regulation by endogenous PTH and PTH1R/ATF4 axis in bone: Implications for bone accrual and strength in growing rats with mild uremia.
    Znorko B; Pawlak D; Oksztulska-Kolanek E; Domaniewski T; Pryczynicz A; Roszczenko A; Rogalska J; Lipowicz P; Doroszko M; Brzoska MM; Pawlak K
    Cytokine; 2018 Jun; 106():19-28. PubMed ID: 29529595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Parathyroid Hormone Senses Extracellular Calcium To Modulate Endocrine Signaling upon Binding to the Family B GPCR Parathyroid Hormone 1 Receptor.
    Culhane KJ; Belina ME; Sims JN; Cai Y; Liu Y; Wang PSP; Yan ECY
    ACS Chem Biol; 2018 Aug; 13(8):2347-2358. PubMed ID: 29952553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Implication of mouse Vps26b-Vps29-Vps35 retromer complex in sortilin trafficking.
    Kim E; Lee Y; Lee HJ; Kim JS; Song BS; Huh JW; Lee SR; Kim SU; Kim SH; Hong Y; Shim I; Chang KT
    Biochem Biophys Res Commun; 2010 Dec; 403(2):167-71. PubMed ID: 21040701
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parathyroid hormone signaling through low-density lipoprotein-related protein 6.
    Wan M; Yang C; Li J; Wu X; Yuan H; Ma H; He X; Nie S; Chang C; Cao X
    Genes Dev; 2008 Nov; 22(21):2968-79. PubMed ID: 18981475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disruption of PTH receptor 1 in T cells protects against PTH-induced bone loss.
    Tawfeek H; Bedi B; Li JY; Adams J; Kobayashi T; Weitzmann MN; Kronenberg HM; Pacifici R
    PLoS One; 2010 Aug; 5(8):e12290. PubMed ID: 20808842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Notch pathway regulates the bone gain induced by PTH anabolic signaling.
    Delgado-Calle J; McAndrews K; Wu G; Orr AL; Ferrari A; Tu X; Srinivasan V; Roodman GD; Ebetino FH; Boeckman RK; Bellido T
    FASEB J; 2022 Mar; 36(3):e22196. PubMed ID: 35137455
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T cells, osteoblasts, and osteocytes: interacting lineages key for the bone anabolic and catabolic activities of parathyroid hormone.
    Pacifici R
    Ann N Y Acad Sci; 2016 Jan; 1364(1):11-24. PubMed ID: 26662934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The parathyroid hormone receptorsome and the potential for therapeutic intervention.
    Mahon MJ
    Curr Drug Targets; 2012 Jan; 13(1):116-28. PubMed ID: 21777186
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Parathyroid hormone-dependent signaling pathways regulating genes in bone cells.
    Swarthout JT; D'Alonzo RC; Selvamurugan N; Partridge NC
    Gene; 2002 Jan; 282(1-2):1-17. PubMed ID: 11814673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. β-arrestin-biased agonism at the parathyroid hormone receptor uncouples bone formation from bone resorption.
    Bohinc BN; Gesty-Palmer D
    Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):112-9. PubMed ID: 21476967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.